SEC Form IRANNOTICE filed by Medtronic plc.
$MDT
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
November 25, 2025
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Notice of disclosure filed in Quarterly Report on Form 10-Q under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the U.S. Securities Exchange Act of 1934, as amended | ||||
Ladies and Gentlemen,
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the U.S. Securities Exchange Act of 1934, as amended, notice is hereby provided that Medtronic plc has made disclosure pursuant to such provisions in its Quarterly Report on Form 10-Q for the period ended October 24, 2025, which was filed with the U.S. Securities and Exchange Commission on November 25, 2025.
Sincerely,
Medtronic plc
| /s/ Denise L. Blomquist | ||
| Denise L. Blomquist | ||
| Vice President, Global Controller and Chief Accounting Officer (Principal Accounting Officer) | ||